Terns Pharmaceuticals (TERN) Short term Debt (2020)
Terns Pharmaceuticals' Short term Debt history spans 1 years, with the latest figure at $12.9 million for Q4 2020.
- For Q4 2020, Short term Debt changed N/A year-over-year to $12.9 million; the TTM value through Dec 2020 reached $12.9 million, changed N/A, while the annual FY2020 figure was $12.9 million, N/A changed from the prior year.
- Short term Debt reached $12.9 million in Q4 2020 per TERN's latest filing.
- In the past five years, Short term Debt ranged from a high of $12.9 million in Q4 2020 to a low of $12.9 million in Q4 2020.